Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2025-12-24 @ 7:44 PM
NCT ID: NCT02526303
Eligibility Criteria: Inclusion Criteria: * Informed consent was obtained * liver cirrhosis * Non-occlusive portal vein thrombosis * No history of variceal bleeding or receive endoscopy or β-blocker for the prevention of patients with G3 or G2 with red marks within 3 months before enrollment * No plan for liver transplantation * Age between 18 and 70 * Child-Pugh score ≤ 11 Exclusion Criteria: * Acute PVT * Fibrotic cord of PV * Isolated splenic vein thrombosis or isolated superior mesenteric vein thrombosis * Extensive superior mesenteric vein thrombosis involving the distal part * Known coagulation disorder besides liver cirrhosis * HCC or other malignant tumor * Patients with G2 varices with red mark or G3 but did not underwent any preventive endoscopy or β-blockers * Platelet count \< 10×109/L * Receive contraceptive, anticoagulation or antiplatelet drug * Receiving thrombolysis treatment * Receiving TIPS or shunting surgery * Bleeding tendency * Recent gastrointestinal bleeding like digestive ulcer or hemorrhagic stroke * Severe portal hypertension,for example, refractory ascite or acute variceal bleeidng * Spontaneous bacterial peritonitis * Severe cardiovascular disorder, endocrine disorder, or mental disease * Major surgery within 6 months * History of organ transplantation * Pregnancy or breast-feeding * History of HIV * Poor compliance
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 70 Years
Study: NCT02526303
Study Brief:
Protocol Section: NCT02526303